Financial results - RETINA MED ZAMFIROIU SRL

Financial Summary - Retina Med Zamfiroiu Srl
Unique identification code: 37478340
Registration number: J23/1923/2017
Nace: 8622
Sales - Ron
968.068
Net Profit - Ron
226.910
Employee
3
The most important financial indicators for the company Retina Med Zamfiroiu Srl - Unique Identification Number 37478340: sales in 2023 was 968.068 euro, registering a net profit of 226.910 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Retina Med Zamfiroiu Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 72.205 290.024 475.581 505.561 781.743 866.379 968.068
Total Income - EUR - - - 72.264 291.004 475.712 508.961 781.749 866.567 969.177
Total Expenses - EUR - - - 10.321 215.651 222.933 227.869 303.154 302.169 720.813
Gross Profit/Loss - EUR - - - 61.943 75.354 252.779 281.093 478.595 564.398 248.364
Net Profit/Loss - EUR - - - 61.221 72.443 248.020 276.488 471.708 556.255 226.910
Employees - - - 1 2 4 4 5 4 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 12.1%, from 866.379 euro in the year 2022, to 968.068 euro in 2023. The Net Profit decreased by -327.658 euro, from 556.255 euro in 2022, to 226.910 in the last year.

Check the financial reports for the company - Retina Med Zamfiroiu Srl

Rating financiar

Financial Rating -
Retina Med Zamfiroiu Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Retina Med Zamfiroiu Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Retina Med Zamfiroiu Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Retina Med Zamfiroiu Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Retina Med Zamfiroiu Srl - CUI 37478340

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 90.187 152.666 128.934 112.128 87.519 76.814 104.408
Current Assets - - - 62.407 85.526 102.200 160.784 408.757 534.039 538.879
Inventories - - - 0 1.562 0 0 0 2.165 945
Receivables - - - 1.578 8.698 7.011 15.946 239.766 405.069 93.418
Cash - - - 60.829 75.266 95.189 144.838 168.991 126.805 444.516
Shareholders Funds - - - 61.264 132.583 248.071 276.538 471.756 556.304 397.417
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 91.330 145.299 13.172 17.267 36.496 58.082 245.870
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 538.879 euro in 2023 which includes Inventories of 945 euro, Receivables of 93.418 euro and cash availability of 444.516 euro.
The company's Equity was valued at 397.417 euro, while total Liabilities amounted to 245.870 euro. Equity decreased by -157.200 euro, from 556.304 euro in 2022, to 397.417 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Retina Med Zamfiroiu Srl

Comments - Retina Med Zamfiroiu Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.